Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

References

• European Centre for Disease Prevention and Control (ECDC). Factsheet about seasonal influenza. 2018 [accessed 2020 Nov 4]. https://ecdc.europa.eu/en/seasonal-influenza/facts/factsheet.
   Google Scholar
• Robert Koch Institute (RKI). Report on the epidemiology of influenza in Germany 2018/2019. 2019. [accessed 2020 Nov 4]. https://www.rki.de/EN/Content/infections/epidemiology/inf_dis_Germany/influenza/summary_2018-19.htm.
   Google Scholar
• Scholz S, Damm O, Schneider U, Ultsch B, Wichmann O, Greiner W. Epidemiology and cost of seasonal influenza in Germany - a claims data analysis. BMC Public Health. 2019;19(1):1090. doi:10.1186/s12889-019-7458-x.
   PubMed Web of Science ®Google Scholar
• Ruf BR, Knuf M. The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr. 2014;173(3):265–10. doi:10.1007/s00431-013-2023-6.
   PubMed Web of Science ®Google Scholar
• Worby CJ, Chaves SS, Wallinga J, Lipsitch M, Finelli L, Goldstein E. On the relative role of different age groups in influenza epidemics. Epidemics. 2015;13:10–16. doi:10.1016/j.epidem.2015.04.003.
   PubMed Web of Science ®Google Scholar
• Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Kruger H, Wahn U, Schaberg T, Schwehm M, et al. The epidemiological impact of childhood influenza vaccination using Live-Attenuated Influenza Vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014;14(1):40. doi:10.1186/1471-2334-14-40.
   PubMedGoogle Scholar
• Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med. 2013;10(10):e1001527. doi:10.1371/journal.pmed.1001527.
   PubMed Web of Science ®Google Scholar
• Plans-Rubio P. The vaccination coverage required to establish herd immunity against influenza viruses. Prev Med. 2012;55(1):72–77. doi:10.1016/j.ypmed.2012.02.015.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Zhu Y, Simonsen L, Mitchel E, Griffin MR. The population impact of a large school-based influenza vaccination campaign. PLoS One. 2010;5(11):e15097. doi:10.1371/journal.pone.0015097.
   PubMedGoogle Scholar
• Eichner M, Schwehm M, Eichner L, Gerlier L. Direct and indirect effects of influenza vaccination. BMC Infect Dis. 2017;17(1):308. doi:10.1186/s12879-017-2399-4.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Weekly epidemiological record. 2012 [accessed 2021 Jun 14]. https://www.who.int/wer/2012/wer8747.pdf?ua=1 .
   Google Scholar
• World Health Organization (WHO). Fact sheet influenza (seasonal). 2018 [accessed 2020 Nov 11]. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Types of seasonal influenza vaccine. 2019 [accessed 2020 Dec 16]. https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/types-of-seasonal-influenza-vaccine.
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Seasonal influenza vaccination and antiviral use in EU/EEA Member States – overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons. Stockholm: ECDC; 2018 [accessed 2020 Nov 4]. https://www.ecdc.europa.eu/sites/default/files/documents/seasonal-influenza-antiviral-use-2018.pdf .
   Google Scholar
• Robert Koch Institute (RKI). Influenza (Teil 1): Erkrankungen durch saisonale Influenzaviren. 2018 [accessed 2022 Apr 11].https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Influenza_saisonal.html;jsessionid=1FFE61FA0C191EB009806C4187EC5F0F.internet102 .
   Google Scholar
• Eichner M, Schwehm M, Hain J, Uphoff H, Salzberger B, Knuf M, Schmidt-Ott R. 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis. 2014;14(1):365. doi:10.1186/1471-2334-14-365.
   PubMedGoogle Scholar
• Epimos. 4Flu model. [accessed 2020 Nov 4]. http://www.4flu.net.
   Google Scholar
• Schmidt-Ott R, Molnar D, Anastassopoulou A, Yanni E, Krumm C, Bekkat-Berkani R, Dos Santos G, Henneke P, Knuf M, Schwehm M, et al. Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations. Hum Vaccin Immunother. 2020;16(4):836–45. doi:10.1080/21645515.2019.1682843.
   PubMedGoogle Scholar
• Schröder-Bernhardi D, Grunow S, Baumann U. Poster P34 - Schutzimpfungen gegen Influenza werden bei Kindern und Jugendlichen äußerst selten durchgeführt – Ergebnisse einer Datenbankanalyse. Presented at: Jahrestagung der deutschen Gesellschaft für Epidemiologie 2014 Sep 17-20; 2014; Ulm, Germany.
   Google Scholar
• Bohmer MM, Walter D, Falkenhorst G, Muters S, Krause G, Wichmann O. Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health. 2012;12(1):938. doi:10.1186/1471-2458-12-938.
   PubMedGoogle Scholar
• Rieck T, Feig M, Wichmann O, Siedler A. Aktuelles aus der KV-Impfsurveillance – Impfquoten der Rotavirus-, Masern-, HPV- und Influenza-Impfung in Deutschland. Epidemiol Bull. 2017;1. doi:10.17886/EpiBull-2017-001.
   Google Scholar
• Robert Koch Institute (RKI). Influenzapandemieplan. 2007 [accessed 2020 Dec 17]. https://edoc.rki.de/bitstream/handle/176904/6227/Pandemieplan2007.pdf?sequence=1&isAllowed=y.
   Google Scholar
• Garcia A, Ortiz de Lejarazu R, Reina J, Callejo D, Cuervo J, Morano Larragueta R. Cost-Effectiveness analysis of quadrivalent influenza vaccine in Spain. Hum Vaccin Immunother. 2016;12(9):2269–77. doi:10.1080/21645515.2016.1182275.
   PubMed Web of Science ®Google Scholar
• Braun S, Behrens T, Kulp W, Eberle A, Greiner W, Ahrens W, von der Schulenburg JMG. Neuraminidasehemmer in der Therapie und Postexpositionsprophylaxe der Influenza. 2005 [accessed 2021 Feb 24]. http://portal.dimdi.de/de/hta/hta_berichte/hta116_bericht_de.pdf.
   Google Scholar
• Ehlken B, Ihorst G, Lippert B, Rohwedder A, Petersen G, Schumacher M, Forster J, Group PS. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr. 2005;164(10):607–15. doi:10.1007/s00431-005-1705-0.
   PubMed Web of Science ®Google Scholar
• Institute for Remuneration System in the Hospital (InEK). Fallpauschalenkatalog 2017. 2017 [accessed 2019 Feb 24]. https://www.g-drg.de/G-DRG-System_2017/Fallpauschalen-Katalog2/Fallpauschalen-Katalog_2017 .
   Google Scholar
• Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–85. doi:10.1093/aje/kwm375.
   PubMed Web of Science ®Google Scholar
• Schmidt-Ott R, Schwehm M, Eichner M. Influence of social contact patterns and demographic factors on influenza simulation results. BMC Infect Dis. 2016;16(1):646. doi:10.1186/s12879-016-1981-5.
   PubMedGoogle Scholar
• DE Statis Statistisches Bundesamt (Federal Statistical Office). Die Datenbank des Statistischen Bundesamtes. 2020 [accessed 2021 Feb 24]. https://www-genesis.destatis.de/genesis/online?operation=sprachwechsel&option=en .
   Google Scholar
• Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74. doi:10.1371/journal.pmed.0050074.
   PubMed Web of Science ®Google Scholar
• Dolk C, Eichner M, Welte R, Anastassopoulou A, Van Bellinghen LA, Poulsen Nautrup B, Van Vlaenderen I, Schmidt-Ott R, Schwehm M, Postma M. Cost-utility of quadrivalent versus trivalent influenza vaccine in Germany, using an individual-based dynamic transmission model. PharmacoEconomics. 2016;34(12):1299–308. doi:10.1007/s40273-016-0443-7.
   PubMed Web of Science ®Google Scholar
• Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. Health Technol Assess. 2009;13(11): iii, ix-xii, 1-246. doi:10.3310/hta13110.
   Web of Science ®Google Scholar
• Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine. 2002;20(19–20):2562–78. doi:10.1016/s0264-410x(02)00154-8.
   PubMed Web of Science ®Google Scholar
• Robert Koch Institute (RKI). Influenza - Was ist bei der Influenza impfung bei Kindern zu beachten? 2019. [accessed 2021 Jul 6]. https://www.rki.de/SharedDocs/FAQ/Impfen/Influenza/FAQ25.html.
   Google Scholar
• Claeys C, Zaman K, Dbaibo G, Li P, Izu A, Kosalaraksa P, Rivera L, Acosta B, Arroba Basanta ML, Aziz A, et al. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons. Lancet Child Adolesc Health. 2018;2(5):338–49. doi:10.1016/S2352-4642(18)30062-2.
   PubMedGoogle Scholar
• Jain VK, Rivera L, Zaman K, Espos RA Jr., Sirivichayakul C, Quiambao BP, Rivera-Medina DM, Kerdpanich P, Ceyhan M, Dinleyici EC, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med. 2013;369(26):2481–91. doi:10.1056/NEJMoa1215817.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2012:Cd004879. doi:10.1002/14651858.CD004879.pub4.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Jefferson T, Al-Ansary LA, Ferroni E, Rivetti A, Di Pietrantonj C. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2014;(3):Cd001269. doi:10.1002/14651858.CD001269.pub5.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010:Cd004876. doi:10.1002/14651858.CD004876.pub3.
   PubMed Web of Science ®Google Scholar
• Boes L, Boedeker B, Schmich P, Wetzstein M, Wichmann O, Remschmidt C. Factors associated with parental acceptance of seasonal influenza vaccination for their children - a telephone survey in the adult population in Germany. Vaccine. 2017;35(30):3789–96. doi:10.1016/j.vaccine.2017.05.015.
   PubMed Web of Science ®Google Scholar
• Scholz SM, Weidemann F, Damm O, Ultsch B, Greiner W, Wichmann O. Cost-effectiveness of routine childhood vaccination against seasonal influenza in Germany. Value Health. 2021;24(1):32–40. doi:10.1016/j.jval.2020.05.022.
   PubMed Web of Science ®Google Scholar
• Brettschneider C, Luck T, Fleischer S, Roling G, Beutner K, Luppa M, Behrens J, Riedel-Heller SG, Konig HH. Cost-utility analysis of a preventive home visit program for older adults in Germany. BMC Health Serv Res. 2015;15(1):141. doi:10.1186/s12913-015-0817-0.
   PubMedGoogle Scholar
• Krejczy M, Harenberg J, Marx S, Obermann K, Frolich L, Wehling M. Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries. J Thromb Thrombolysis. 2014;37(4):507–23. doi:10.1007/s11239-013-0989-6.
   PubMed Web of Science ®Google Scholar
• Federal Statistical Office. Current population; 2018 [accessed 2018 Aug 2]. https://www.destatis.de/EN/Themes/Society-Environment/Population/Current-Population/_node.html.
   Google Scholar
• Kindergesundheit-info.de. Kinderkrankengeld und Freistellung von der Arbeit. 2021 [accessed 2021 Jun 14]. https://www.kindergesundheit-info.de/themen/krankes-kind/recht/berufstaetigkeit/.
   Google Scholar
• Robert Koch Institute (RKI). Modelling methods for predicting epidemiological and health economic effects of vaccinations. Guidance for analyses to be presented to the German Standing Committee on Vaccination (STIKO); 2016 [accessed 2020 Dec 23]. http://www.rki.de/EN/Content/infections/Vaccination/methodology/Guidance_for_analyses.pdf?__blob=publicationFile .
   Google Scholar
• Janssen B, Szende A. Population norms for the EQ-5D. In: Szende A; Janssen B, and Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. Dordrecht (NL), New York: Springer; 2014. p. 30.
   Google Scholar
• Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol. 2006;164(10):936–44. doi:10.1093/aje/kwj317.
   PubMed Web of Science ®Google Scholar
• Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Kruger H, Greiner W. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ. 2015;16(5):471–88. doi:10.1007/s10198-014-0586-4.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). WHO Europe/ECDC joint statement: Low uptake of seasonal influenza vaccination in Europe may jeopardize capacity to protect people in next pandemic; 2018 [accessed 2021 Feb 24]. https://www.euro.who.int/en/media-centre/sections/press-releases/2018/who-europeecdc-joint-statement-low-uptake-of-seasonal-influenza-vaccination-in-europe-may-jeopardize-capacity-to-protect-people-in-next-pandemic .
   Google Scholar
• World Health Organization (WHO). Flu awareness campaign 2020; 2020. [accessed Feb 24]. https://www.euro.who.int/en/media-centre/events/events/2020/10/flu-awareness-campaign-2020.
   Google Scholar
• de Boer PT, van Maanen BM, Damm O, Ultsch B, Dolk FCK, Crépey P, Pitman R, Wilschut JC, Postma MJ. A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2017;17(3):249–65. doi:10.1080/14737167.2017.1343145.
   PubMed Web of Science ®Google Scholar
• Ting EEK, Sander B, Ungar WJ. Systematic review of the cost-effectiveness of influenza immunization programs. Vaccine. 2017;35(15):1828–43. doi:10.1016/j.vaccine.2017.02.044.
   PubMed Web of Science ®Google Scholar
• Rajaram S, Wiecek W, Lawson R, Blak BT, Zhao Y, Hackett J, Brody R, Patel V, Amzal B. Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: a Bayesian model-based approach. PLoS One. 2017;12(12):e0186739. doi:10.1371/journal.pone.0186739.
   PubMed Web of Science ®Google Scholar
• Public Health England (PHE). Flu vaccination 2020 to 2021 - programme briefing for schools; 2020. https://www.gov.im/media/1369934/imm-62-0308-flu-school-headteachers-facts.pdf.
   Google Scholar
• Gerlier L, Lamotte M, Greneche S, Lenne X, Carrat F, Weil-Olivier C, Damm O, Schwehm M, Eichner M. Assessment of public health and economic impact of intranasal live-attenuated influenza vaccination of children in France using a dynamic transmission model. Appl Health Econ Health Policy. 2017;15(2):261–76. doi:10.1007/s40258-016-0296-4.
   PubMed Web of Science ®Google Scholar
• Perman S, Turner S, Ramsay AI, Baim-Lance A, Utley M, Fulop NJ. School-based vaccination programmes: a systematic review of the evidence on organisation and delivery in high income countries. BMC Public Health. 2017;17(1):252. doi:10.1186/s12889-017-4168-0.
   PubMed Web of Science ®Google Scholar
• Muhamad NA, Buang SN, Jaafar S, Jais R, Tan PS, Mustapha N, Lodz NA, Aris T, Sulaiman LH, Murad S. Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme. BMC Public Health. 2018;18(1):1402. doi:10.1186/s12889-018-6316-6.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Schaffer S, Rand CM, Vincelli P, Eagan A, Goldstein NP, Hightower AD, Younge M, Blumkin A, Albertin CS, et al. School-Located influenza vaccinations: a randomized trial. Pediatrics. 2016;138(5). doi:10.1542/peds.2016-1746.
   Web of Science ®Google Scholar
• UK Department of Health. The seasonal flu immunisation programme 2011/12 (Table 1); 2011 [accessed 2020 Dec 16]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_128175.pdf .
   Google Scholar
• Chit A, Roiz J, Aballea S. An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model. PLoS One. 2015;10(7):e0133606. doi:10.1371/journal.pone.0133606.
   PubMed Web of Science ®Google Scholar
• Thommes EW, Ismaila A, Chit A, Meier G, Bauch CT. Cost-Effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. BMC Infect Dis. 2015;15(1):465. doi:10.1186/s12879-015-1193-4.
   PubMedGoogle Scholar
• Reuters. European cities plead for more flu shots as winter looms, pandemic rages; 2020 [accessed 2021 Feb 24]. https://www.reuters.com/article/us-health-coronavirus-eu-flu/european-cities-plead-for-more-flu-shots-as-winter-looms-pandemic-rages-idUKKBN2771PD.
   Google Scholar